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Depression can influence pain and vice versa, yet the biological mechanisms underlying how one
influences the pathophysiology of the other remains unclear. Dysregulation of locus coeruleus-
noradrenergic transmission is implicated in both conditions, although it is not known whether
this effect is exacerbated in cases of co-morbid depression and chronic pain. We studied locus
coeruleus activity using immunofluorescence and electrophysiological approaches in rats
subjected to unpredictable chronic mild stress (CMS, an experimental model of depression)
and/or chronic constriction injury (CCI, a model of chronic neuropathic pain) for 2 weeks. CCI
alone had no effect on any of the locus coeruleus parameters studied, while CMS led to a slight
reduction in the electrophysiological activity of the locus coeruleus. Furthermore, CMS was
associated with an increase in the number of tyrosine hydroxylase-positive cells in the locus
coeruleus, although they were smaller in size. Interestingly, these effects of CMS were
exacerbated when combined with CCI, even though no changes in the α2-adrenoreceptors or
the noradrenaline transporter were observed in any group. Together, these findings suggest that
CMS triggers several modifications in locus coeruleus-noradrenergic transmission that are
exacerbated by co-morbid chronic pain.
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1. Introduction
Depression and chronic pain frequently co-exist, and they can
mutually exacerbate one another, worsening the patient0s
prognosis and treatment response (Bair et al., 2004; Karp
et al., 2005). It is unclear whether depression and chronic pain
are causally related, or whether diagnosis with one condition
implies a predisposition to the other. We previously investi-
gated the complex relationship between these conditions in
animal models of depression, pain, and co-morbid depression
and pain (Bravo et al., 2012). In rats subjected to chronic mild
stress (CMS), which induces depressive-like behavior, we
observed minimal changes in sensorial pain perception. More-
over, depressive-like behavior in these animals was unaffected
by chronic constriction injury (CCI), a commonly used model of
neuropathic pain. However, we observed increased avoidance
of painful stimuli in animals subjected to CMS. Moreover, we
subsequently demonstrated that in rats with neuropathic pain,
social stress exacerbates aversion to painful experiences
through a locus coeruleus (LC)-related mechanism (Bravo
et al., 2013). Moreover, LC impairment coincides with the
onset of anxio-depressive-like symptoms in rats suffering
chronic neuropathic pain (Alba-Delgado et al., 2013). Together,
these findings point to a key role of the LC in the interaction
between chronic pain and depression.
The LC is the main site of noradrenergic cell bodies in the
CNS. Descending projections from the LC to the spinal cord
block nociceptive inputs, while projections ascending to the
forebrain regulate emotional responses (Haidkind et al.,
2003). Although the involvement of the LC in both pain and
depression has been well established, its role in comorbid
pain and depression remains unclear. Accordingly, we have
addressed this issue by analyzing LC activity in an animal
model of co-morbid depression and chronic neuropathic pain.
2. Experimental procedures
2.1. Animals and experimental design
Experimental procedures were approved by the Committee for
Animal Experimentation at the University of Cadiz in accordance
with governmental guidelines and they complied with the Interna-
tional Association for the Study of Pain ethical guidelines
(Zimmermann, 1983). After a period of habituation in standard
conditions, male Sprague-Dawley rats (280–300 g) were subjected
to chronic stress and/or neuropathic pain for 2 weeks (Figure 1A).
Neuropathic pain was induced by chronic constriction injury (CCI) of
the common left sciatic nerve (Figure 1B: (Bennett and Xie, 1988;
Berrocoso and Mico, 2007). In sham-operated rats, an identical
dissection was performed but the sciatic nerve was not ligated. To
induce a depressive-like state, animals were individually and
continuously subjected to CMS (Figure 1C) in sessions lasting 10–
14 h (day and night). Control animals were not subjected to any
stress.
2.2. Behavioral tests
At the end of the habituation period and throughout the experi-
mental phase, sensory pain was evaluated in all the experimental
groups. Mechanical allodynia was measured using the von Frey test
(Ugo Basile, Italy) by applying a vertical force to the paw, with a
cut-off at 50 g (Berrocoso et al., 2011). The latency of paw
withdrawal was recorded. Cold allodynia was measured using the
acetone test, whereby a 100 ml drop of acetone was applied to the
center of the hindpaw with a pipette, and the response was graded
to a four-point scale: 0, no response; 1, paw withdrawal; 2,
repeated paw flicking; 3, paw licking. The mean score value was
calculated according to: (summation score value of each trials/
number of total trials) (Bravo et al., 2012).
Behavioral despair was evaluated in one set of animals at the end
of the experimental period using the modified forced swimming test
(mFST). Rats were placed for 15 min in Plexiglas cylinders filled
with 30 cm of water (pre-test session), and again for 5 min 24 h
later (test session). The animal0s behavior (immobility, swimming or
climbing) was assessed throughout the test session (Bravo et al.,
2012; Detke et al., 1995). Administration of the noradrenaline
reuptake inhibitor, desipramine (20 mg/kg, i.p.; Sigma-Aldrich,
USA), was used as a positive control in a parallel group and it was
administered 23.5, 5 and 1 h before testing.
2.3. Electrophysiology
Single-unit extracellular recordings of LC neurons were obtained as
described in Supplementary material (Alba-Delgado et al., 2012;
Berrocoso and Mico, 2007).
2.4. Western blot
Rats were sacrificed by administering an overdose of chloral
hydrate, and the LC was removed bilaterally to assess the presence
of the noradrenaline transporter (NAT) (Supplementary material).
Protein expression was detected using a LI-COR Odysseys two-
channel quantitative fluorescence imaging system (Bonsai Advanced
Techonologies, Spain) and the digital images were analyzed by densi-
tometry using ImageJ software (National Institutes of Health, USA).
2.5. Immunohistochemistry
Tyrosine hydroxylase (TH) immunohistochemistry of LC sections was
performed as described in Supplementary material. The fluorescent
signal was visualized on an Olympus BX60 microscope equipped with a
U-MNU filter system and coupled to Olympus DP71 camera (Olympus,
USA). TH-immunoreactive (TH-IR) cells were counted manually in an
average of 6 LC sections per animal (n=4–5 rats per group). To detect
changes in soma size, the mean soma area per group was calculated in
7–9 randomly selected TH-IR cells per section. Each TH-IR soma was
outlined manually using a computer mouse and the cross-sectional
area was calculated with ImageJ software.
2.6. Statistics
The data are represented as the mean7SEM. The results were
analyzed using either an unpaired Student t test or two- or three-way
analysis of variance (ANOVA), with or without repeated measures, as
appropriate. All post-hoc analyses were carried out using a Bonfer-
roni post-hoc test. Burst incidence was analyzed using Fisher0s exact
test. The differences were considered significant at po0.05.
3. Results
We first performed a behavioral analyses of each experi-
mental groups and in agreement with our previous findings
(Bravo et al., 2012) no differences in mechanical or cold
allodynia in the injured hind-paw were observed between
the two groups subjected to neuropathic pain (CCI-control
and CCI-CMS; Figure 1D and F). In both CMS groups (sham-
CMS and CCI-CMS), we detected cold but not mechanical
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allodynia in the non-injured paw (Figure 1G and E). All CMS
groups developed depressive-like behavior, as witnessed by
an increase in immobility with respect to the sham-control
and CCI-control (Figure 1H). This increase in immobility
was offset by a decrease in the time spent climbing
(Figure 1J). By contrast, sham operated animals treated
with desipramine spent less time immobile and more time
climbing than their untreated counterparts (Student t test:
po0.01; Figure 1H and J).
When spontaneous electrophysiological activity was stu-
died to evaluate LC functionality (Table 2), the firing rates
in the sham-control animals were similar to those in the
neuropathic pain (CCI-control) and CMS (sham-CMS) (Figure 2A
and Table 2). However, the combination of neuropathic pain
and CMS (CCI-CMS) resulted in a decrease in firing activity with
respect to both the sham-control and CCI-control (po0.01
po0.05; Figure 2A and B and Table 2). The histograms of the
interspike interval (ISI) for sham-control and CCI-control
revealed a similar Gaussian distribution of 0.5–0.6 s (Figure 2C
and Table 2), reflecting a normal pattern of discharge. However,
a shift to the right in the distribution (0.8 s) was observed in the
sham-CMS and CCI-CMS groups (Figure 2D and Table 2). When
the firing rate of one LC neuron had stabilized, UK14,304 or DMI
was administered intravenously to evaluate α2-adrenoceptor
Figure 1 Experimental design and behavioral tests. Top left: schemes illustrating the (A) experimental schedule, and the protocols
used for (B) chronic constriction injury and (C) chronic mild stress (animals were subjected to two unpredictable stressors each day
for two weeks). Bottom left: withdrawal response of (D) the ipsilateral and (E) contralateral hindpaws in the von Frey test. Graphs
show the cold allodynia score for the (F) ipsilateral and (G) contralateral hindpaws. Right: forced swimming test results showing the
time spent (H) immobile, (I) swimming and (J) climbing. Data represent the mean+S.E.M. of 8–9 rats per group: nnpo0.05,
nnpo0.01 and nnnpo0.001 vs. sham-control; + +po0.01, + + +po0.001 vs. sham-CMS; ##po0.01, ###po0.001 vs. CCI-control.
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and NAT function, respectively. Both drugs inhibited sponta-
neous activity in a dose-dependent manner, producing
similar dose–response curves in all experimental groups
(Figure 2E and F and Table 2). NAT expression in the LC
was also determined in another set of animals and two-way
ANOVA revealed no differences between groups (Figure 3I
and Table 1), consistent with our electrophysiological data.
Finally, there was no change in the number of TH-IR
neurons in animals that experienced pain alone vs. sham-
control (Figure 3A–H). By contrast, there was a tendency for
the number of TH-IR neurons to increase in sham-CMS with
respect to the sham-control group, an increase that was
significant when compared to the CCI-control (po0.05).
Interestingly, this difference was even more pronounced in
Table 2 Electrophysiological properties of LC neurons. Spontaneous activity in response to CCI and/or CMS (mean7S.E.M.).
Values in parentheses represent the proportion of neurons exhibiting burst activity. Values in square brackets represent the
number of neurons pharmacologically tested. A total of 12–15 rats per group were used: npo0.05, nnpo0.01 vs. sham-control;
#po0.05, ##po0.01, ###po0.001 vs. CCI-control. ISI, mean interspike interval.
Sham-control CCI-control Sham-CMS CCI-CMS
Spontaneous activity
Firing rate (Hz) 1.870.1 1.870.1 1.570.1 1.370.1nn##
ISI (s) 0.670.0 0.570.0 0.870.1## 0.870.0nn
###
Burst firing activity
Incidence (%) 42.9 (12/28) 38.5 (10/26) 19.2 (5/26)n 13.8 (4/29)n#
Burst rate (burst/ms) 7.171.8 8.172.4 3.171.4 1.470.7n#
Spikes per burst 2.370.2 2.170.1 2.070.0 2.070.0
Spikes in burst (%) 2.070.3 2.070.4 1.670.4 1.670.3
Effective dose 50
UK14,304 (μg/kg) 21.872.9 [6] 16.673.0 [4] 24.076.1 [5] 24.775.6 [7]
Desipramine (mg/kg) 0.370.1 [6] 0.270.0 [5] 0.270.0 [7] 0.370.0 [8]
Figure 2 Electrophysiological activity. (A) Spontaneous firing rate of LC neurons in response to CCI and/or CMS. (B) Percentage
burst firing during spontaneous activity (12–15 rats per group were evaluated (mean+S.E.M.): npo0.05, nnpo 0.01 vs. sham-control;
#po0.05, ##po 0.01 vs. CCI-control. (C,D) Representative ISI histograms showing the patterns of electrical discharge recorded in
(C) sham-control and (D) CCI-CMS (bin=10 s). (E,F) Dose–response curves illustrating the inhibitory effect of (E) UK14,304 and
(F) desipramine. The data represent the mean7S.E.M. of the percentage decrease from the basal firing rate (4–8 neurons
pharmacologically tested).
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the CCI-CMS animals with respect to the sham-control and
CCI-control (po0.05, po0.01 respectively; Figure 3G).
Further analyses revealed significant changes in the fre-
quency distribution of cell size. Around 90% of the cells in
the control groups had a well-defined oval soma and a large,
easily visible nucleus, and they were larger than 200 mm2
(Figure 3H, C and D). However, we found fewer cells of this
size range in the CMS groups, with an increase in the
proportion of smaller cells (50–200 mm2; Figure 3H). These
smaller neurons had a more irregular and rounded morphol-
ogy and in some cases their nucleus was barely visible
(Figure 3E and F).
4. Discussion
We investigated the changes in noradrenergic transmission
associated with co-morbid depression and pain using a combi-
nation of two well established animal models. Our findings
suggest that pain exacerbates the changes in LC-noradrenergic
transmission associated with depression.
Chronic pain was induced in rats by constriction of the
sciatic nerve, which results in a rapid, long lasting and
stable decrease in the pain threshold, while depressive-like
behavior was induced by the CMS protocol, whereby a
depressive-like state gradually develops over time in
response to unpredictable stresses. By combining these
approaches, we sought to mimic the clinical situation in
which patients with chronic pain must cope with stressful
events. In these conditions, our electrophysiological ana-
lyses revealed a general decrease in LC activity in CCI-CMS
compared with their corresponding controls, and as wit-
nessed by a decrease in firing rate and burst activity. Lower
electrical activity has been correlated with reduced nora-
drenaline release in the LC and terminal fields in rats
(Berridge and Abercrombie, 1999; Florin-Lechner et al.,
1996). Although no marked electrophysiological changes
were detected in CMS rats, we observed a clear trend
Figure 3 Effect of neuropathic pain and CMS on TH, soma size and NAT expression in LC neurons. (A,B) Representative
photomicrographs showing TH expression (in red) in sections from (A) sham-control and (B) CCI-CMS (n=4–5 per group). Scale bar:
100 mm. (C–F) Representative photomicrographs showing large neurons (arrows) in (C) sham-control and (D) CCI-control. Note the
high proportion of small neurons (arrowheads) in the (E) sham-CMS and (F) CCI-CMS. Scale bar: 20 mm. (G,H) Graphs depicting (G) the
number of TH-IR neurons in the LC and (H) the frequency distribution of TH-IR soma size for each experimental group. Note the
larger proportion of small neurons (o200 mm2) in sham-CMS and CCI-CMS (inset). The data are expressed as the mean+S.E.M.:
npo0.05, nnpo0.01, nnnpo0.001 vs. sham-control; #po0.05, ##po0.01, ###po0.001 vs. CCI-control; +po0.05, + + +po0.001 vs.
sham-CMS. (I) Quantitative analysis of NAT expression. The data represent the mean+S.E.M. of 5 assays performed on LC samples
from 6 rats per group. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of
this article.)
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towards diminished spontaneous LC activity in stressed
animals, an effect that became evident when neuropathic
pain was combined with CMS. This decrease in electrical
activity was accompanied by an increase in the number of
TH-IR cells in CCI-CMS and sham-CMS animals with respect
to their controls. This increase in TH expression would
suggest higher concentration of noradrenaline because TH
is the rate-limiting enzyme in its synthesis. However, it also
might reflect a compensatory response to the decrease in
noradrenaline induced by CMS (reduced electrical activity).
For example, noradrenaline synthesis (downstream TH) or
catabolism (elevated monoamine oxidase levels (Meyer
et al., 2006)) might be altered. Although the effect was
slightly higher in CCI-CMS animals, it was not significantly
different to the increase in the sham-CMS group. Hence,
neuropathic pain does not apparently modify TH expression
in animals subjected to CMS, or alternatively, a ceiling
threshold may exist. Surprisingly, TH-IR cells had a smaller
soma in sham-CMS than in control animals, an effect that
was further exaggerated in CCI-CMS. In animal models of
neurodegenerative disorders, the shrinkage of TH-IR cells in
the LC has often been described (German et al., 2005; Polak
et al., 2011). Other microstructural changes in the LC and
degeneration of noradrenergic axons have also been demon-
strated in the frontal cortex in rats subjected to long-term
stress (Kitayama et al., 1997; Kitayama et al., 2008).
Together and waiting for additional morphological studies,
these observations suggest that CCI exacerbates the neuro-
nal damage induced by stress. Although the absolute number
of TH-IR neurons increased in CMS animals, our electrophy-
siological data revealed a decrease in their activity, a finding
that should be confirmed in further studies measuring
noradrenaline levels in the LC and projection areas (frontal
cortex and spinal cord) in basal and evoked conditions (after
a painful or stressful event). Furthermore, we detected no
changes in NAT or α2-adrenoceptor expression, indicating
that the changes observed in spontaneous activity are
probably caused by another neurotransmitter, possibly GABA
(Bravo et al., 2013; Dimitrov et al., 2013).
Taken together, our immunohistochemical and electro-
physiological findings suggest that CMS induces several
modifications at the level of the LC that are exacerbated
by chronic pain. The increased impairment of the LC seen in
CCI-CMS may be explained by alterations in the emotional
component of pain interpretation, as pain perception
remained constant throughout the experimental period. In
the mFST, similar immobility and climbing scores were
recorded for sham-CMS and CCI-CMS animals, suggesting
that CMS dysregulates the noradrenergic system and subse-
quently impairs the capacity to cope in stressful situations.
However, although no differences were detected between
groups, it is likely that depressive-like behavior developed
earlier in the co-morbid situation. We previously demon-
strated increased avoidance of painful paw stimulation in
animals exhibiting depressive-like behavior (Bravo et al.,
2012), suggesting that LC impairment might contribute to
the augmented perception of pain in CCI-CMS vs. CCI-control.
In conclusion, our findings in an animal model of co-
morbid pain and depression demonstrate that neuropathic
pain exacerbates the changes induced by CMS at the level of
the LC. CMS results in an increase in the number of TH-IR
cells and a concomitant decrease in the size of these cells,
effects that were exacerbated by neuropathic pain. Thus,
functional impairment of these cells appears to contribute
to a decrease in spontaneous LC activity, which in turn
might impair the appropriate emotional response to harmful
stimuli, such as pain and stress.
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